How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Ebola
As the European Commission grants Marketing Authorization for the company's Ebola vaccine regimen—a key step towards enabling broader access to it for the people who need it most—we share top facts about the vaccine for the deadly virus.
Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.
Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.
From a first-of-its-kind contact lens that darkens when exposed to bright light to the first donation of 500,000 doses of an Ebola vaccine, here are just some of the ways Johnson & Johnson helped change the trajectory of health for humanity this past year.
The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world's second largest outbreak of the disease.
Macaya Douoguih volunteered to lead an accelerated clinical program for a new investigational Ebola vaccine at the height of the 2014 epidemic in West Africa. She reflects on her experiences—and why her work must continue today.
These up-and-coming stars in oncology, immunology, anti-aging, vaccines and other areas of research are helping to change healthcare as we know it. And they're just at the beginning of their brilliant careers.
Cancer. HIV/AIDS. Ebola. These are just some of the causes these under-30 movers and shakers plan to impact with their bright ideas for change at a one-of-a-kind summit in Colombia.
From helping stop the spread of disease in public bathrooms in Uganda to supporting local farmers in Liberia, these savvy troubleshooters have devised simple healthcare solutions with serious impact.
Johnson & Johnson's Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.
What started as support for wounded soldiers shortly after the company's founding has evolved into a legacy of philanthropy that spans the globe. We look at key moments throughout history when the company has mobilized to help people, including those recently affected by earthquakes in Puerto Rico.
Johnson & Johnson has created life-saving medications, sanity-saving baby products and so much more—and none of it would have been possible without female leaders at its core.
The Ebola epidemic in West Africa has subsided, but there is still much work to be done in the aftermath of the crisis—both on the healthcare and the humanitarian front.
